Andrew Darlington is a Cardiology physician. OpenAlex indexes 46 publications with 1,095 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1267 Highway 54 W
Suite 2200
Fayetteville, GA 302142114
Telephone
404-605-2800Registry record last updated 14 Apr 2017.
Industry payments
36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202563 payments$58,440openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202527 payments$29,626openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202525 payments$27,395openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.3%Beta blocker14.2%Metoprolol Succinate49%Carvedilol35%Metoprolol Tartrate12%Sotalol2%Atenolol1%Bisoprolol Fumarate1%Part D<11 patientsLoop diuretic9.6%Furosemide58%Torsemide30%Bumetanide11%Part D≥202 patients+ 23 more classes in this area
Metabolism & gastrointestinal
14.6%SGLT2 inhibitor9.7%Farxiga56%Jardiance41%Dapagliflozin3%Part D≥146 patientsPotassium supplement3.5%Potassium Chloride83%Klor-Con M2010%Klor-Con M107%Part D<11 patients+ 3 more classes in this area
Blood & clotting
11.3%Factor Xa inhibitor8.8%Eliquis79%Xarelto21%Part D≥165 patientsP2Y12 inhibitor1.1%Clopidogrel100%Part D≥35 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”